These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 18777498)
21. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood? Léger J; Danner S; Simon D; Garel C; Czernichow P J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901 [TBL] [Abstract][Full Text] [Related]
22. Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiency. Kołtowska-Häggström M; Geffner ME; Jönsson P; Monson JP; Abs R; Hána V; Höybye C; Wollmann HA J Clin Endocrinol Metab; 2010 Jun; 95(6):2646-54. PubMed ID: 20335451 [TBL] [Abstract][Full Text] [Related]
23. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. Christopher M; Hew FL; Oakley M; Rantzau C; Alford F J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675 [TBL] [Abstract][Full Text] [Related]
24. Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. Attanasio AF; Howell S; Bates PC; Frewer P; Chipman J; Blum WF; Shalet SM J Clin Endocrinol Metab; 2002 Jul; 87(7):3368-72. PubMed ID: 12107251 [TBL] [Abstract][Full Text] [Related]
25. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency. Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020 [TBL] [Abstract][Full Text] [Related]
26. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Högler W; Briody J; Moore B; Lu PW; Cowell CT Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578 [TBL] [Abstract][Full Text] [Related]
27. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents. Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486 [TBL] [Abstract][Full Text] [Related]
29. GH secretory pattern in young adults who discontinued GH treatment for GH deficiency and decreased longitudinal growth in childhood. Svensson J; Johannsson G; Iranmanesh A; Albertsson-Wikland K; Veldhuis JD; Bengtsson BA Eur J Endocrinol; 2006 Jul; 155(1):91-9. PubMed ID: 16793954 [TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD). Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776 [TBL] [Abstract][Full Text] [Related]
31. Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. Svensson J; Fowelin J; Landin K; Bengtsson BA; Johansson JO J Clin Endocrinol Metab; 2002 May; 87(5):2121-7. PubMed ID: 11994351 [TBL] [Abstract][Full Text] [Related]
32. Unfavourable impact of growth hormone (GH) discontinuation on body composition and cholesterol profiles after the completion of height growth in GH-deficient young adults. Kohno H; Ueyama N; Honda S Diabetes Obes Metab; 1999 Sep; 1(5):293-6. PubMed ID: 11225641 [TBL] [Abstract][Full Text] [Related]
33. GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency. Giavoli C; Profka E; Verrua E; Ronchi CL; Ferrante E; Bergamaschi S; Sala E; Malchiodi E; Lania AG; Arosio M; Ambrosi B; Spada A; Beck-Peccoz P J Clin Endocrinol Metab; 2012 Nov; 97(11):3983-8. PubMed ID: 22904173 [TBL] [Abstract][Full Text] [Related]
34. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board. Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630 [TBL] [Abstract][Full Text] [Related]
35. Muscle strength and power, maximum oxygen consumption, and body composition in middle-aged short-stature adults with childhood-onset growth hormone deficiency. Sartorio A; Agosti F; De Col A; Mazzilli G; Marazzi N; Busti C; Galli R; Lafortuna CL Arch Med Res; 2008 Jan; 39(1):78-83. PubMed ID: 18067999 [TBL] [Abstract][Full Text] [Related]
36. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency. Franco C; Johannsson G; Bengtsson BA; Svensson J J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452 [TBL] [Abstract][Full Text] [Related]
37. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency. Hoybye C; Jönsson P; Monson JP; Koltowska-Häggström M; Hána V; Geffner M; Abs R Eur J Endocrinol; 2007 Nov; 157(5):589-96. PubMed ID: 17984238 [TBL] [Abstract][Full Text] [Related]
38. Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency. Ramistella V; Wasniewska M; Arasi S; Catena M; Velletri MR; Corica D; Santucci S; De Luca F Pediatr Med Chir; 2014 Dec; 36(5-6):104. PubMed ID: 25669895 [TBL] [Abstract][Full Text] [Related]